350 related articles for article (PubMed ID: 36081518)
1. A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer.
Ding K; He Y; Wei J; Fu S; Wang J; Chen Z; Zhang H; Qu Y; Liang K; Gong X; Qiu L; Chen D; Xiao B; Du H
Front Immunol; 2022; 13():943090. PubMed ID: 36081518
[TBL] [Abstract][Full Text] [Related]
2. DNA Damage Response Evaluation Provides Novel Insights for Personalized Immunotherapy in Glioma.
Chen M; Huang B; Zhu L; Wang Q; Pang Y; Cheng M; Lian H; Liu M; Zhao K; Xu S; Zhang J; Zhong C
Front Immunol; 2022; 13():875648. PubMed ID: 35720326
[TBL] [Abstract][Full Text] [Related]
3. Patient-Level DNA Damage Repair Pathway Profiles and Anti-Tumor Immunity for Gastric Cancer.
Lou S; Wang Y; Zhang J; Yin X; Zhang Y; Wang Y; Xue Y
Front Immunol; 2021; 12():806324. PubMed ID: 35082793
[TBL] [Abstract][Full Text] [Related]
4. DNA damage response and PD-1/PD-L1 pathway in ovarian cancer.
Zhang T; Zheng S; Liu Y; Li X; Wu J; Sun Y; Liu G
DNA Repair (Amst); 2021 Jun; 102():103112. PubMed ID: 33838550
[TBL] [Abstract][Full Text] [Related]
5. Mutations in DNA damage response pathways as a potential biomarker for immune checkpoint blockade efficacy: evidence from a seven-cancer immunotherapy cohort.
Zhang W; Zhang L; Jiang H; Li Y; Wang S; Wang Q
Aging (Albany NY); 2021 Nov; 13(21):24136-24154. PubMed ID: 34747718
[TBL] [Abstract][Full Text] [Related]
6. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
Li J; Tang LL; Ma J
BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
[TBL] [Abstract][Full Text] [Related]
7. Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy.
Ye Z; Shi Y; Lees-Miller SP; Tainer JA
Front Immunol; 2021; 12():797880. PubMed ID: 34970273
[TBL] [Abstract][Full Text] [Related]
8. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
Arjumand W; Asiaf A; Ahmad ST
Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
[TBL] [Abstract][Full Text] [Related]
9. Copy Number Amplification of DNA Damage Repair Pathways Potentiates Therapeutic Resistance in Cancer.
Wu Z; Li S; Tang X; Wang Y; Guo W; Cao G; Chen K; Zhang M; Guan M; Yang D
Theranostics; 2020; 10(9):3939-3951. PubMed ID: 32226530
[No Abstract] [Full Text] [Related]
10. Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors.
Arora S; Velichinskii R; Lesh RW; Ali U; Kubiak M; Bansal P; Borghaei H; Edelman MJ; Boumber Y
Adv Ther; 2019 Oct; 36(10):2638-2678. PubMed ID: 31410780
[TBL] [Abstract][Full Text] [Related]
11. Activation of the DDR Pathway Leads to the Down-Regulation of the TGFβ Pathway and a Better Response to ICIs in Patients With Metastatic Urothelial Carcinoma.
Zhou C; Lin A; Cao M; Ding W; Mou W; Guo N; Chen Z; Zhang J; Luo P
Front Immunol; 2021; 12():634741. PubMed ID: 34220801
[TBL] [Abstract][Full Text] [Related]
12. DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes.
Vidotto T; Nersesian S; Graham C; Siemens DR; Koti M
J Immunother Cancer; 2019 Jun; 7(1):148. PubMed ID: 31174611
[TBL] [Abstract][Full Text] [Related]
13. Targeting DNA damage response and repair genes to enhance anticancer immunotherapy: rationale and clinical implication.
Lamberti G; Andrini E; Sisi M; Federico AD; Ricciuti B
Future Oncol; 2020 Aug; 16(23):1751-1766. PubMed ID: 32539551
[TBL] [Abstract][Full Text] [Related]
14. Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy.
Huang JL; Chang YT; Hong ZY; Lin CS
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328658
[TBL] [Abstract][Full Text] [Related]
15. Uncover DNA damage and repair-related gene signature and risk score model for glioma.
Wu Y; Liu L; Huang D; Li Z; Xu R; Cheng M; Chen L; Wang Q; You C
Ann Med; 2023 Dec; 55(1):2200033. PubMed ID: 37086071
[TBL] [Abstract][Full Text] [Related]
16. Interfaces between cellular responses to DNA damage and cancer immunotherapy.
Pilger D; Seymour LW; Jackson SP
Genes Dev; 2021 May; 35(9-10):602-618. PubMed ID: 33888558
[TBL] [Abstract][Full Text] [Related]
17. An insight into understanding the coupling between homologous recombination mediated DNA repair and chromatin remodeling mechanisms in plant genome: an update.
Banerjee S; Roy S
Cell Cycle; 2021 Sep; 20(18):1760-1784. PubMed ID: 34437813
[TBL] [Abstract][Full Text] [Related]
18. Diverse immune response of DNA damage repair-deficient tumors.
Qing T; Jun T; Lindblad KE; Lujambio A; Marczyk M; Pusztai L; Huang KL
Cell Rep Med; 2021 May; 2(5):100276. PubMed ID: 34095878
[TBL] [Abstract][Full Text] [Related]
19. Triple kill: DDR inhibitors, radiotherapy and immunotherapy leave cancer cells with no escape.
Qiu Y; Hu X; Zeng X; Wang H
Acta Biochim Biophys Sin (Shanghai); 2022 Oct; 54(11):1569-1576. PubMed ID: 36305726
[TBL] [Abstract][Full Text] [Related]
20. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
